Both in Biotechnology
LENZ Therapeutics vs Outlook Therapeutics
Over the past year LENZ returned −87.3% and OTLK returned −64.1%; their daily moves had a correlation of 0.12.
LENZ −87.3% OTLK −64.1%Growth of $1, one year, split-adjusted
| Metric | LENZ | OTLK |
|---|---|---|
| Price | $3.55 | $0.4668 |
| Market cap | $111.5M | $113.6M |
| Today | +16.39% | −0.51% |
| 1 month | −1.1% | −21.6% |
| 6 months | −60.9% | +93.1% |
| Year to date | −77.8% | −70.5% |
| 1 year | −88.1% | −63.0% |
| Revenue growth (YoY) | +9.7% | −99.4% |
| Gross margin | 94.9% | −95.0% |
| Net margin | −581.8% | −233554.9% |
| P/E (TTM) | — | — |
| Price / sales | 5.2× | — |
| Net cash | $220.0M | -$7.0M |
| Dividend yield | — | — |
| Volatility (60d) | 77.2% | 89.0% |
| Short % of float | 46.7% | 39.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).